Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to evaluate the performance of HEMOBLASTâ„¢ compared to FLOSEAL in cardiothoracic operations.


Clinical Trial Description

A maximum of 104 subjects will be enrolled across a maximum of 5 study sites in the United States.

The estimated duration of the study is approximately 8 months from the time of first subject enrollment to the last subject enrollment. Enrollment occurs intraoperatively after confirmation of the intraoperative eligibility criteria. Subjects will undergo intraoperative performance assessments and then will be discontinued from the study after completion of the intraoperative visit. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03725098
Study type Interventional
Source Biom'Up SA
Contact
Status Completed
Phase N/A
Start date March 1, 2019
Completion date June 28, 2019

See also
  Status Clinical Trial Phase
Recruiting NCT05968456 - Complexity and Frailty in Cardiothoracic and Vascular Anesthesia (CAfCA). Prospective Multicentric Observational Study
Enrolling by invitation NCT04065919 - Evaluation of Liposomal Bupivacaine Compared to Usual Care and Its Effects on Pain for Cardiac Surgery Phase 4
Not yet recruiting NCT05079724 - Acute Kidney Injury After Cardiac Surgery
Completed NCT01847859 - Pocket-size Ultrasound by Nurses in Cardiothoracic Post-operative Patients N/A
Terminated NCT01897519 - A Safety and Efficacy Trial of Multiple Dosing Regimens of ABT-719 for the Prevention of Acute Kidney Injury in Subjects Undergoing High Risk Surgery Phase 2
Recruiting NCT02863250 - Australian and New Zealand Massive Transfusion Registry
Terminated NCT00075179 - Natrecor in Pulmonary Hypertension Phase 4
Recruiting NCT02029534 - Intensive Statin Therapy Effect on Post-Operative Atrial Fibrillation (POAF) Phase 4
Recruiting NCT03639519 - A Trial to Assess the Impact of Ascorbic Acid on Cardiac Surgeries Outcomes and Complications'' Phase 4